Appili Therapeutics Ratios and Metrics

Market cap in millions CAD. Fiscal year is April - March.

Millions CAD. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 3, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Market Cap	3	4	4	5	9	70
Market Cap Growth	-37.63%	-	-12.50%	-43.28%	-87.73%	120.84%
Enterprise Value	14.9	3.75	5.03	9.94	6.77	54.51
Last Close Price	0.02	0.04	0.04	0.04	0.12	1.11
Forward PE	-	-	-	-	-	3.27
PS Ratio	12.83	42.26	5.13	14.52	6.15	-
P/FCF Ratio	-	4.90	-	-	-	-
P/OCF Ratio	-	4.89	-	-	-	-
EV/Sales Ratio	72.20	37.36	6.07	29.74	4.87	-
EV/FCF Ratio	-	4.33	-	-	-	-
Debt / Equity Ratio	-0.04	-0.05	-0.08	-1.02	-1.49	0.07
Debt / FCF Ratio	-	14.19	-	-	-	-
Net Debt / EBITDA Ratio	-1.31	-0.55	-0.58	-0.65	0.07	0.89
Net Debt / FCF Ratio	-1080.81	12.77	-3.24	-0.51	0.09	1.32
Asset Turnover	0.16	0.04	0.36	0.06	0.10	0
Quick Ratio	0.02	0.18	0.11	0.97	1.21	3.86
Current Ratio	0.03	0.19	0.13	1.05	1.24	3.96
Return on Equity (ROE)	79.07%	178.89%	171.24%	164.81%	-577.03%	-156.50%
Return on Assets (ROA)	-717.17%	-884.20%	-605.68%	-141.69%	-193.83%	-114.94%
Return on Invested Capital (ROIC)	-85.11%	-210.56%	-370.57%	-3812.71%	-13028.20%	-13132.50%
Return on Capital Employed (ROCE)	65.98%	175.94%	281.73%	-911.03%	-336.21%	-144.26%
FCF Yield	-	20.41%	-	-	-	-
Buyback Yield / Dilution	-4.39%	0.00%	-6.62%	-70.43%	-12.76%	-74.81%
Total Shareholder Return	-4.39%	0.00%	-6.62%	-70.43%	-12.76%	-74.81%